- EPIX Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
F-3 Filing
ESSA Pharma (EPIX) F-3Shelf registration (foreign)
Filed: 22 Jan 18, 12:00am
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference of our report dated December 11, 2017, relating to the consolidated statements of financial position of ESSA Pharma Inc. (the “Company”) as ofSeptember 30, 2017 and 2016, and the related consolidated statements of loss and comprehensive loss, changes in shareholders’ equity (deficiency), and cash flows for the years ended September 30, 2017, 2016, and 2015 of the Company and the reference to our name in the “Experts” section in the Company’s registration statement on FormF-3 filed with the U.S. Securities and Exchange Commission on January 22, 2018.
“DAVIDSON & COMPANY LLP”
Vancouver, Canada | Chartered Professional Accountants | |
January 22, 2018 |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.